StemCell Institute (7096) Reports Earnings: Operating Income of 40 Million Yen and Net Income of 35 Million Yen

StemCell Institute (7096) has released its financial results, reporting net sales of 722 million yen and operating income of 40 million yen. Ordinary income stood at 43 million yen, while net income attributable to owners of the parent reached 35 million yen, with earnings per share (EPS) of 3.57 yen. Comprehensive income was recorded at 17 million yen.

Regarding the financial structure and valuation metrics, the company maintains an equity ratio of 31.9% and retained earnings of 1.63 billion yen, against interest-bearing debt of 610 million yen. Profitability indicators show a return on equity (ROE) of 1.32% and a return on assets (ROA) of 0.42%. Market participants will likely continue to monitor future improvements in capital efficiency and profitability trends.